Samy Suissa

Dec 30, 2024 | bmj.com | William B. Feldman |Samy Suissa |Aaron S. Kesselheim |Jerry Avorn

Research BMJ 2024; 387 doi: https://doi.org/10.1136/bmj-2024-080409 Cite this as: BMJ 2024;387:e080409 Linked Editorial Environmentally friendly inhaler regimens for COPD William B Feldman, assistant professor1 2 3, Samy Suissa, professor4, Aaron S Kesselheim, professor1 3, Jerry Avorn, professor1 3, Massimiliano Russo, assistant professor5, Sebastian Schneeweiss, professor1 3, Shirley V Wang, associate professor1 3 1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of...

Apr 5, 2024 | gut.bmj.com | Samy Suissa |Ruben Hernaez

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Mar 18, 2024 | gut.bmj.com | Samy Suissa |Ruben Hernaez

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Jan 15, 2024 | bpspubs.onlinelibrary.wiley.com | Samy Suissa

1 INTRODUCTION The randomized controlled trial (RCT) forms the basis for the approval of drugs by regulatory agencies and for clinical management guidelines.

Nov 30, 2023 | pharmexec.com | Samy Suissa |Meg Richards

In recent years, the healthcare landscape has seen the rapid generation and accessibility of real-world data (RWD), spurred on by significant advancements in technology. As even more RWD becomes available, regulators and researchers are increasingly leveraging observational studies to analyze RWD and produce real-world evidence (RWE) to identify new indications for approved products.